These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35588943)

  • 1. The role of arylamine N-acetyltransferases in chronic degenerative diseases: Their possible function in the immune system.
    Hernández-González O; Herrera-Vargas DJ; Martínez-Leija ME; Zavala-Reyes D; Portales-Pérez DP
    Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119297. PubMed ID: 35588943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction.
    Choudhury C; Gill MK; McAleese CE; Butcher NJ; Ngo ST; Steyn FJ; Minchin RF
    Pharmacol Rev; 2024 Feb; 76(2):300-320. PubMed ID: 38351074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
    Smelt VA; Mardon HJ; Sim E
    Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
    Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
    Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and Functional Characterization of
    Uno Y; Uehara S; Ijiri M; Kawaguchi H; Asano A; Shiraishi M; Banju K; Murayama N; Yamazaki H
    Drug Metab Dispos; 2022 Nov; 50(11):1429-1433. PubMed ID: 35768074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Functional Characterization of N-Acetyltransferases NAT1 and NAT2 in Cynomolgus Macaque.
    Uno Y; Murayama N; Yamazaki H
    Chem Res Toxicol; 2018 Nov; 31(11):1269-1276. PubMed ID: 30358977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.
    Sim E; Abuhammad A; Ryan A
    Br J Pharmacol; 2014 Jun; 171(11):2705-25. PubMed ID: 24467436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
    Walraven JM; Doll MA; Hein DW
    J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
    Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
    Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function studies of human arylamine N-acetyltransferases NAT1 and NAT2. Functional analysis of recombinant NAT1/NAT2 chimeras expressed in Escherichia coli.
    Dupret JM; Goodfellow GH; Janezic SA; Grant DM
    J Biol Chem; 1994 Oct; 269(43):26830-5. PubMed ID: 7929420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Arylamine N-acetyltransferase 1 and miR-1290 Levels in Childhood Acute Lymphoblastic Leukemia: A Pilot Study.
    Hernandez-Gonzalez O; Del Carmen Milan-Segovia R; Zavala-Reyes D; Alvarado-Zamarripa DM; Ortiz-Zamudio JJ; Correa-Gonzalez LC; Vargas-Morales JM; Uresti-Rivera EE; Portales-Perez DP
    In Vivo; 2023; 37(3):1129-1144. PubMed ID: 37103073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the role of the highly conserved residues Arg9 and Arg64 in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis.
    Deloménie C; Goodfellow GH; Krishnamoorthy R; Grant DM; Dupret JM
    Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):207-15. PubMed ID: 9173883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
    Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
    Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.
    Hernández-González O; Ortiz-Zamudio JJ; Rodríguez-Pinal CJ; Alvarado-Morales I; Martínez-Jiménez VDC; Salazar-González RA; Correa-González LC; Gómez R; Portales-Pérez DP; Milán-Segovia RDC
    Leuk Lymphoma; 2018 Aug; 59(8):1968-1975. PubMed ID: 29214875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants of N-acetyltransferases 1 and 2 (NAT1 and NAT2) in cynomolgus and rhesus macaques.
    Uno Y; Murayama N; Yamazaki H
    Biochem Pharmacol; 2020 Jul; 177():113996. PubMed ID: 32339492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal distribution of arylamine N-acetyltransferases in the intestine of the hamster, mouse, and rat. Evidence for multiplicity of N-acetyltransferases in the intestine.
    Ware JA; Svensson CK
    Biochem Pharmacol; 1996 Nov; 52(10):1613-20. PubMed ID: 8937477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
    Liu L; Wagner CR; Hanna PE
    Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
    Tsirka T; Boukouvala S; Agianian B; Fakis G
    Gene; 2014 Feb; 536(1):65-73. PubMed ID: 24333853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.